Servizo
Oncoloxía radioterápica
Artigos (8) Publicacións nas que participase algún/ha investigador/a
2020
-
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)
Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1378-1389
-
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12
-
Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: A prospective phase II study
Radiation Oncology, Vol. 15, Núm. 1
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
-
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455
-
Impact of previous admission to an intensive care unit on stem cell transplantation outcome
Medicina Clinica, Vol. 155, Núm. 9, pp. 382-387
-
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
Journal of the National Cancer Institute, Vol. 112, Núm. 2, pp. 179-190
-
SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection
Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 7, pp. 391-399